Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · IEX Real-Time Price · USD
0.810
-0.010 (-1.21%)
Feb 6, 2023, 12:06 PM EST - Market open
-1.21%
Market Cap 10.65M
Revenue (ttm) 5,760
Net Income (ttm) -2.60M
Shares Out 12.83M
EPS (ttm) -0.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 73,544
Open 0.820
Previous Close 0.820
Day's Range 0.800 - 0.840
52-Week Range 0.540 - 29.000
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About VRAX

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared the... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Jul 21, 2022
Employees 5
Stock Exchange NASDAQ
Ticker Symbol VRAX
Full Company Profile

Financial Performance

Financial Statements

News

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

LONDON , Feb. 2, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), today announced that Mr. James Foster, Chief Executive Officer of Virax, has issued a lette...

4 days ago - PRNewsWire

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Kit Available Now for Distribution LONDON , Jan. 4, 2023 /PRNewswire/ -- Virax Biolabs ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detecti...

1 month ago - PRNewsWire

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Kits available Now for Distribution LONDON , Dec. 6, 2022 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prev...

2 months ago - PRNewsWire

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

LONDON , Nov. 15, 2022 /PRNewswire/ -- Virax Biolabs ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral disease...

2 months ago - PRNewsWire

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

LONDON , Nov. 8, 2022 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of ...

3 months ago - PRNewsWire

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

LONDON , Nov. 4, 2022 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of ...

3 months ago - PRNewsWire

Why Is Virax (VRAX) Stock Up 40% Today?

Small-cap business Virax Biolabs (NASDAQ: VRAX) isn't often in the headlines, but today is a special day for the company. Reportedly, Virax's new rapid testing kit is a triple-threat.

3 months ago - InvestorPlace

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Kits available in November for Distribution LONDON , Nov. 3, 2022 /PRNewswire/ -- Virax Biolabs ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention...

3 months ago - PRNewsWire

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

LONDON , Oct. 26, 2022 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagn...

3 months ago - PRNewsWire

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

Exclusive distribution agreement signed with Cosmos Holdings Inc. (Nasdaq: COSM), providing for exclusive distribution rights in Greece and Cyrus with the opportunity for Cosmos to distribute across E...

Other symbols: COSM
4 months ago - PRNewsWire

Why Is Virax Biolabs (VRAX) Stock Up 40% Today?

Source: Gorodenkoff / Shutterstock.com No question about it — traders are taking notice of Virax Biolabs (NASDAQ: VRAX) today. That's because VRAX stock is soaring 40% this morning after Virax reveal...

4 months ago - InvestorPlace

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

LONDON , Sept. 12, 2022 /PRNewswire/ -- Virax Biolabs ("Virax" or the "Company") (NASDAQ: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseas...

5 months ago - PRNewsWire

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

LONDON , Sept. 6, 2022 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of...

5 months ago - PRNewsWire

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

LONDON , Aug. 16, 2022 /PRNewswire/ -- Virax Biolabs ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral disease...

6 months ago - PRNewsWire

VRAX Stock Alert: Why Is Virax Biolabs Up 120% Today?

Virax Biolabs (NASDAQ: VRAX), a specialist in diagnostic tests, veritably captured the market news cycle today, with its shares skyrocketing 120% before giving up some ground in the afternoon session...

6 months ago - InvestorPlace

Monkeypox Stocks GOVX, VRAX, SIGA Rocket on Vaccine Shortage Fears

Monkeypox stocks are rallying amid worries about a shortage of vaccines for the illness in the U.S. Additionally, in recent days, New York state, New York City and San Francisco have issued emergency ...

Other symbols: GOVXSIGA
6 months ago - InvestorPlace

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Kits Available in July for Distribution Kits Available in July for Distribution

6 months ago - GlobeNewsWire

Investors May Want to Follow Progress of VC-Backed Medtechs

At least one group is bullish about the outlook for the medtech industry: venture capitalists.

Other symbols: BHCBLCOMDTMHUATNON
6 months ago - GuruFocus

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

London, United Kingdom, July 21, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detectio...

7 months ago - GlobeNewsWire

Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

London, United Kingdom, July 20, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detectio...

7 months ago - GlobeNewsWire